| 000 | 01912 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250515170455.0 | ||
| 264 | 0 | _c20090630 | |
| 008 | 200906s 0 0 eng d | ||
| 022 | _a0004-3591 | ||
| 024 | 7 |
_a10.1002/art.24494 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHemmatazad, Hossein | |
| 245 | 0 | 0 |
_aHistone deacetylase 7, a potential target for the antifibrotic treatment of systemic sclerosis. _h[electronic resource] |
| 260 |
_bArthritis and rheumatism _cMay 2009 |
||
| 300 |
_a1519-29 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aBlotting, Western |
| 650 | 0 | 4 | _aCells, Cultured |
| 650 | 0 | 4 |
_aCollagen Type I _xbiosynthesis |
| 650 | 0 | 4 |
_aCollagen Type III _xbiosynthesis |
| 650 | 0 | 4 |
_aConnective Tissue Growth Factor _xanalysis |
| 650 | 0 | 4 |
_aEnzyme Inhibitors _xtherapeutic use |
| 650 | 0 | 4 |
_aExtracellular Matrix Proteins _xanalysis |
| 650 | 0 | 4 |
_aFibroblasts _xdrug effects |
| 650 | 0 | 4 | _aHistone Deacetylase Inhibitors |
| 650 | 0 | 4 |
_aHistone Deacetylases _xanalysis |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHydroxamic Acids _xtherapeutic use |
| 650 | 0 | 4 |
_aIntercellular Adhesion Molecule-1 _xanalysis |
| 650 | 0 | 4 | _aPolymerase Chain Reaction |
| 650 | 0 | 4 |
_aScleroderma, Systemic _xdrug therapy |
| 650 | 0 | 4 |
_aSkin _xdrug effects |
| 650 | 0 | 4 |
_aTransforming Growth Factor beta _xtherapeutic use |
| 700 | 1 | _aRodrigues, Hanna Maciejewska | |
| 700 | 1 | _aMaurer, Britta | |
| 700 | 1 | _aBrentano, Fabia | |
| 700 | 1 | _aPileckyte, Margarita | |
| 700 | 1 | _aDistler, Jörg H W | |
| 700 | 1 | _aGay, Renate E | |
| 700 | 1 | _aMichel, Beat A | |
| 700 | 1 | _aGay, Steffen | |
| 700 | 1 | _aHuber, Lars C | |
| 700 | 1 | _aDistler, Oliver | |
| 700 | 1 | _aJüngel, Astrid | |
| 773 | 0 |
_tArthritis and rheumatism _gvol. 60 _gno. 5 _gp. 1519-29 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/art.24494 _zAvailable from publisher's website |
| 999 |
_c18834767 _d18834767 |
||